Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ricerca Biosciences | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Ricerca Biosciences

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

R. Ian Lennox has been appointed executive chairman at Ricerca Biosciences, LLC. Mr. Lennox is co-founder of Impax/Fairway Capital, which manages more than $500 million of investment assets including CMDF Life Sciences funds. He was formerly chief executive officer of pharmaceutical and biotechnology markets at MDS, chief executive officer at Phoenix International Life Sciences, and executive chairman and chief executive officer at Drug Royalty Corp. Mr. Lennox’s career began at Monsanto Co. where for almost 20 years he held various leadership positions in both U.S. and international operations.

“We are delighted to welcome Ian Lennox to Ricerca. He brings global life sciences experience and a track record of accomplishment in our industry,” stated Tom Bradshaw, chief executive officer, Ricerca Biosciences. “Ian has already commenced work with the board and is focused on attracting additional scientific and management talents as well as resources required to implement Ricerca’s new business plan,” commented board member Sengal Selassie, Cowen Investment Holdings, LLC.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters